激素治疗后痛经减轻是子宫内膜异位症严重程度的标志
法国大学医院2004年1月至2019年12月的回顾性观察队列研究,纳入578例经组织学证实子宫内膜异位症且有术前疼痛症状的未孕42岁以下女性,评估抑制性激素治疗后痛经缓解与疾病表型的关系。痛经减轻者占88.2%(510例),其深部浸润型子宫内膜异位症(DIE)肠道病灶发生率更高(45.7% vs 30.8%,P=0.01),多发性DIE病灶比例更高(72.8% vs 56.4%,P=0.02);多因素分析显示痛经减轻仍与严重DIE表型显著相关(校正OR 3.9,95%CI 2.0至7.6,P<0.001)。结论认为痛经减轻与DIE表型相关,是疾病更严重的标志。
要点
- 抑制性激素治疗后痛经减轻者占88.2%(510/578)。
- 痛经减轻组DIE肠道病灶比例45.7% vs 30.8%(P=0.01)。
- 痛经减轻与严重DIE表型相关(校正OR 3.9,95%CI 2.0至7.6)。
核心结论
- 在子宫内膜异位症女性中,抑制性激素治疗后痛经减轻与DIE表型相关,是疾病更严重的标志。
研究设计与样本
- 法国大学医院2004年1月至2019年12月开展的回顾性观察队列研究。
- 纳入未孕、42岁以下、术前接受抑制性激素治疗后痛经缓解测试且组织学证实子宫内膜异位症的女性。
- 共578例经组织学证实子宫内膜异位症且有术前疼痛症状的患者,按抑制性激素测试结果分组比较。
主要发现
- 抑制性激素治疗后痛经减轻率为88.2%(510/578)。
- 痛经减轻组DIE肠道病灶发生率为45.7%(233/510),无痛经减轻组为30.8%(21/68),P=0.01。
- 痛经减轻组多发性DIE病灶(两个或以上)比例为72.8%(287/394),无痛经减轻组为56.4%(22/39),P=0.02。
- 多因素分析显示痛经减轻仍与严重DIE表型显著相关(校正OR 3.9,95%CI 2.0至7.6,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is a decrease in dysmenorrhoea after suppressive hormonal therapy a marker of the endometriosis phenotype and of greater disease severity? DESIGN: Retrospective observational cohort study conducted in a French university hospital, between January 2004 and December 2019. Non-pregnant women aged younger than 42 years, who tested for dysmenorrhoea relief after suppressive hormonal therapy before surgery, and who had histological confirmation of endometriosis, were included. The comparisons were carried out according to the results of the suppressive hormonal test. RESULTS: Of the 578 histologically proven endometriosis patients with preoperative pain symptoms, the rate of dysmenorrhoea decrease after suppressive hormonal therapy was 88.2% (n = 510). These patients had a higher incidence of deep infiltrating endometriosis (DIE) intestinal lesions (45.7% [233/510] versus 30.8% [21/68], P = 0.01) and an increased rate of multiple DIE lesions (two or more) (72.8% [287/394] versus 56.4% [22/39], P = 0.02). After multivariate analysis, decrease of dysmenorrhoea after suppressive hormonal therapy remained significantly associated with the severe DIE phenotype (adjusted OR 3.9, 95% CI 2.0 to 7.6, P < 0.001). CONCLUSION: In women with endometriosis, a decrease of dysmenorrhoea after suppressive hormonal therapy is associated with the DIE phenotype and is a marker of greater severity.
引用
- Marcellin L, Bourdon M, Houdre D, et al. Decrease of dysmenorrhoea with hormonal treatment is a marker of endometriosis severity. Reprod Biomed Online. 2023. PMID: 36959070. doi:10.1016/j.rbmo.2023.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。